Pressmeddelande

BioStock: Chosa develops next generation chemotherapy

Cision Publicerad: 13 Jun 2023 09:45

The chemotherapy cisplatin has been a staple in cancer treatment since the 1980s. However, not all cancer patients respond to the drug, and the side effects are quite severe. Chosa Oncology is looking to tackle both of these drawbacks with its iCIP concept. BioStock has taken a closer look at this revolutionary cancer treatment and how the company is working to take it to the next level.

Read the full article at biostock.se:

https://www.biostock.se/en/2023/06/chosa-develops-next-generation-chemotherapy/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Nyheter om CHOSA Oncology

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!